• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型的乳酸脱氢酶抑制剂,1-(苯硒基)-4-(三氟甲基)苯,通过细胞凋亡导致的细胞死亡抑制肿瘤生长。

A Novel Lactate Dehydrogenase Inhibitor, 1-(Phenylseleno)-4-(Trifluoromethyl) Benzene, Suppresses Tumor Growth through Apoptotic Cell Death.

机构信息

Department of Korean Medical Science, School of Korean Medicine and Healthy Aging Korean Medical Research Center, Pusan National University, Yangsan, Gyeongnam, 50612, Republic of Korea.

Department of Molecular Biology, College of Natural Science, Pusan National University, Geumjeong-gu, Busan, 46241, Republic of Korea.

出版信息

Sci Rep. 2019 Mar 8;9(1):3969. doi: 10.1038/s41598-019-40617-3.

DOI:10.1038/s41598-019-40617-3
PMID:30850682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6408513/
Abstract

The Warburg effect, wherein cancer cells prefer glycolysis rather than oxidative phosphorylation even under normoxic conditions, is a major characteristic of malignant tumors. Lactate dehydrogenase A (LDHA) is the main enzyme regulating the Warburg effect, and is thus, a major target for novel anti-cancer drug development. Through our ongoing screening of novel inhibitors, we found that several selenobenzene compounds have inhibitory effects on LDHA activity. Among them, 1-(phenylseleno)-4-(trifluoromethyl) benzene (PSTMB) had the most potent inhibitory effect on the enzymatic activity of LDHA. The results from biochemical assays and computational modeling showed that PSTMB inhibited LDHA activity. In addition, PSTMB inhibited the growth of several tumor cell lines, including NCI-H460, MCF-7, Hep3B, A375, HT29, and LLC. In HT29 human colon cancer cells, PSTMB dose-dependently inhibited the viability of the cells and activity of LDHA, without affecting the expression of LDHA. Under both normoxic and hypoxic conditions, PSTMB effectively reduced LDHA activity and lactate production. Furthermore, PSTMB induced mitochondria-mediated apoptosis of HT29 cells via production of reactive oxygen species. These results suggest that PSTMB may be a novel candidate for development of anti-cancer drugs by targeting cancer metabolism.

摘要

瓦博格效应(Warburg effect),即在常氧条件下,癌细胞更倾向于糖酵解而不是氧化磷酸化,这是恶性肿瘤的主要特征之一。乳酸脱氢酶 A(LDHA)是调节瓦博格效应的主要酶,因此是新型抗癌药物开发的主要靶点。通过我们正在进行的新型抑制剂筛选,我们发现几种硒苯化合物对 LDHA 活性具有抑制作用。其中,1-(苯硒基)-4-(三氟甲基)苯(PSTMB)对 LDHA 的酶活性抑制作用最强。生化测定和计算建模结果表明,PSTMB 抑制了 LDHA 的活性。此外,PSTMB 抑制了包括 NCI-H460、MCF-7、Hep3B、A375、HT29 和 LLC 在内的几种肿瘤细胞系的生长。在 HT29 人结肠癌细胞中,PSTMB 呈剂量依赖性地抑制细胞活力和 LDHA 活性,而不影响 LDHA 的表达。在常氧和缺氧条件下,PSTMB 均可有效降低 LDHA 活性和乳酸的产生。此外,PSTMB 通过产生活性氧诱导 HT29 细胞线粒体介导的细胞凋亡。这些结果表明,PSTMB 可能是通过靶向肿瘤代谢开发抗癌药物的新型候选药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/8e2862cee3ce/41598_2019_40617_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/330fee76e19c/41598_2019_40617_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/e03aa7cb8857/41598_2019_40617_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/61defad1c412/41598_2019_40617_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/b8955d4fd39d/41598_2019_40617_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/a7a0ddf8ed43/41598_2019_40617_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/b2157e003068/41598_2019_40617_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/d932707f9a61/41598_2019_40617_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/8e2862cee3ce/41598_2019_40617_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/330fee76e19c/41598_2019_40617_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/e03aa7cb8857/41598_2019_40617_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/61defad1c412/41598_2019_40617_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/b8955d4fd39d/41598_2019_40617_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/a7a0ddf8ed43/41598_2019_40617_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/b2157e003068/41598_2019_40617_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/d932707f9a61/41598_2019_40617_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/588c/6408513/8e2862cee3ce/41598_2019_40617_Fig8_HTML.jpg

相似文献

1
A Novel Lactate Dehydrogenase Inhibitor, 1-(Phenylseleno)-4-(Trifluoromethyl) Benzene, Suppresses Tumor Growth through Apoptotic Cell Death.一种新型的乳酸脱氢酶抑制剂,1-(苯硒基)-4-(三氟甲基)苯,通过细胞凋亡导致的细胞死亡抑制肿瘤生长。
Sci Rep. 2019 Mar 8;9(1):3969. doi: 10.1038/s41598-019-40617-3.
2
Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.双重基因敲除乳酸脱氢酶 A 和 B 是消除“Warburg 效应”所必需的,该效应限制了肿瘤生长到氧化代谢。
J Biol Chem. 2018 Oct 12;293(41):15947-15961. doi: 10.1074/jbc.RA118.004180. Epub 2018 Aug 29.
3
Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.一种靶向人乳酸脱氢酶A的强效抑制剂的鉴定及其对癌细胞系的代谢调控
Bioorg Med Chem Lett. 2016 Jan 1;26(1):72-5. doi: 10.1016/j.bmcl.2015.11.025. Epub 2015 Nov 10.
4
Lactate dehydrogenase downregulation mediates the inhibitory effect of diallyl trisulfide on proliferation, metastasis, and invasion in triple-negative breast cancer.乳酸脱氢酶下调介导二烯丙基三硫化物对三阴性乳腺癌增殖、转移和侵袭的抑制作用。
Environ Toxicol. 2017 Apr;32(4):1390-1398. doi: 10.1002/tox.22333. Epub 2016 Aug 27.
5
Myristica fragrans Suppresses Tumor Growth and Metabolism by Inhibiting Lactate Dehydrogenase A.肉豆蔻通过抑制乳酸脱氢酶A来抑制肿瘤生长和代谢。
Am J Chin Med. 2016;44(5):1063-79. doi: 10.1142/S0192415X16500592. Epub 2016 Jul 19.
6
Structural and functional regulation of lactate dehydrogenase-A in cancer.肿瘤中乳酸脱氢酶-A 的结构与功能调节。
Future Med Chem. 2020 Mar;12(5):439-455. doi: 10.4155/fmc-2019-0287. Epub 2020 Feb 17.
7
Development of human lactate dehydrogenase a inhibitors: high-throughput screening, molecular dynamics simulation and enzyme activity assay.人乳酸脱氢酶 A 抑制剂的开发:高通量筛选、分子动力学模拟和酶活性测定。
J Comput Aided Mol Des. 2024 Aug 10;38(1):28. doi: 10.1007/s10822-024-00568-y.
8
Development of novel human lactate dehydrogenase A inhibitors: High-throughput screening, synthesis, and biological evaluations.新型人乳酸脱氢酶 A 抑制剂的研发:高通量筛选、合成与生物学评价。
Eur J Med Chem. 2019 Sep 1;177:105-115. doi: 10.1016/j.ejmech.2019.05.033. Epub 2019 May 17.
9
Synthesis and initial screening of lactate dehydrogenase inhibitor activity of 1,3-benzodioxole derivatives.1,3-苯并二氧杂环戊烯衍生物的合成及乳酸脱氢酶抑制活性的初步筛选。
Sci Rep. 2020 Nov 16;10(1):19889. doi: 10.1038/s41598-020-77056-4.
10
Metabolic plasticity underpins innate and acquired resistance to LDHA inhibition.代谢可塑性为 LDHA 抑制的先天和获得性耐药提供了基础。
Nat Chem Biol. 2016 Oct;12(10):779-86. doi: 10.1038/nchembio.2143. Epub 2016 Aug 1.

引用本文的文献

1
Therapeutic Strategies Targeting Aerobic Glycolysis in Cancer and Dynamic Monitoring of Associated Metabolites.针对癌症有氧糖酵解的治疗策略及相关代谢物的动态监测
Cells. 2025 Aug 19;14(16):1288. doi: 10.3390/cells14161288.
2
Dual role of lactate in human health and disease.乳酸在人类健康与疾病中的双重作用。
Front Physiol. 2025 Aug 1;16:1621358. doi: 10.3389/fphys.2025.1621358. eCollection 2025.
3
Deciphering enemy tactics - the narrow path to an optimal anti-cancer strategy targeting the Warburg effect.解读敌人的战术——通向针对瓦伯格效应的最佳抗癌策略的狭窄道路。

本文引用的文献

1
Revealing the potency of Annona muricata leaves extract as FOXO1 inhibitor for diabetes mellitus treatment through computational study.通过计算研究揭示番荔枝叶提取物作为糖尿病治疗中FOXO1抑制剂的潜力。
In Silico Pharmacol. 2016 Dec;5(1):3. doi: 10.1007/s40203-017-0023-3. Epub 2017 Jun 26.
2
Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin.氧杂蒽酮的手性衍生物:对映选择性对环氧化酶(COX-1和COX-2)抑制作用及与人血清白蛋白结合相互作用的影响研究
Pharmaceuticals (Basel). 2017 May 31;10(2):50. doi: 10.3390/ph10020050.
3
Pharmacol Rep. 2025 Aug 1. doi: 10.1007/s43440-025-00768-9.
4
Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets.癌症进展中的代谢适应:优化策略与治疗靶点
Cancers (Basel). 2025 Jul 15;17(14):2341. doi: 10.3390/cancers17142341.
5
Dual inhibition of oxidative phosphorylation and glycolysis using a hyaluronic acid nanoparticle NOX inhibitor enhanced response to radiotherapy in colorectal cancer.使用透明质酸纳米颗粒NOX抑制剂双重抑制氧化磷酸化和糖酵解可增强结直肠癌对放疗的反应。
Biomaterials. 2025 Dec;323:123437. doi: 10.1016/j.biomaterials.2025.123437. Epub 2025 May 26.
6
Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives.乳酸对肿瘤微环境中免疫细胞功能的影响:机制与治疗前景
Front Immunol. 2025 Mar 26;16:1563303. doi: 10.3389/fimmu.2025.1563303. eCollection 2025.
7
Lactate-induced protein lactylation in cancer: functions, biomarkers and immunotherapy strategies.癌症中乳酸诱导的蛋白质乳酰化:功能、生物标志物及免疫治疗策略
Front Immunol. 2025 Jan 10;15:1513047. doi: 10.3389/fimmu.2024.1513047. eCollection 2024.
8
Metabolic adaptations to acute glucose uptake inhibition converge upon mitochondrial respiration for leukemia cell survival.对急性葡萄糖摄取抑制的代谢适应集中在线粒体呼吸以维持白血病细胞存活。
Cell Commun Signal. 2025 Jan 25;23(1):47. doi: 10.1186/s12964-025-02044-y.
9
Progress in Lactate Metabolism and Its Regulation via Small Molecule Drugs.乳酸代谢及其通过小分子药物进行调控的研究进展
Molecules. 2024 Nov 29;29(23):5656. doi: 10.3390/molecules29235656.
10
Lactate: a rising star in tumors and inflammation.乳酸:肿瘤与炎症领域的一颗新星。
Front Immunol. 2024 Nov 26;15:1496390. doi: 10.3389/fimmu.2024.1496390. eCollection 2024.
FX11 inhibits aerobic glycolysis and growth of neuroblastoma cells.
FX11抑制神经母细胞瘤细胞的有氧糖酵解和生长。
Surgery. 2017 Mar;161(3):747-752. doi: 10.1016/j.surg.2016.09.009. Epub 2016 Dec 2.
4
Myristica fragrans Suppresses Tumor Growth and Metabolism by Inhibiting Lactate Dehydrogenase A.肉豆蔻通过抑制乳酸脱氢酶A来抑制肿瘤生长和代谢。
Am J Chin Med. 2016;44(5):1063-79. doi: 10.1142/S0192415X16500592. Epub 2016 Jul 19.
5
Discovery of 2-((3-cyanopyridin-2-yl)thio)acetamides as human lactate dehydrogenase A inhibitors to reduce the growth of MG-63 osteosarcoma cells: Virtual screening and biological validation.发现2-((3-氰基吡啶-2-基)硫代)乙酰胺作为人乳酸脱氢酶A抑制剂以减少MG-63骨肉瘤细胞的生长:虚拟筛选和生物学验证
Bioorg Med Chem Lett. 2016 Aug 15;26(16):3984-7. doi: 10.1016/j.bmcl.2016.06.083. Epub 2016 Jun 30.
6
ROS homeostasis and metabolism: a dangerous liason in cancer cells.活性氧(ROS)稳态与代谢:癌细胞中的危险关联
Cell Death Dis. 2016 Jun 9;7(6):e2253. doi: 10.1038/cddis.2016.105.
7
Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer Chemotherapy.人乳酸脱氢酶5(hLDH5)抑制剂的最新进展:癌症化疗的一种有前景的方法
J Med Chem. 2016 Jan 28;59(2):487-96. doi: 10.1021/acs.jmedchem.5b00168. Epub 2015 Sep 4.
8
Search for Human Lactate Dehydrogenase A Inhibitors Using Structure-Based Modeling.基于结构建模寻找人类乳酸脱氢酶A抑制剂
Acta Naturae. 2015 Apr-Jun;7(2):57-63.
9
JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer.JQ1通过下调卵巢癌中的乳酸脱氢酶A(LDHA)来抑制肿瘤生长。
Oncotarget. 2015 Mar 30;6(9):6915-30. doi: 10.18632/oncotarget.3126.
10
Mitochondrial reactive oxygen species and cancer.线粒体活性氧与癌症。
Cancer Metab. 2014 Nov 28;2:17. doi: 10.1186/2049-3002-2-17. eCollection 2014.